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Introduction 
Myocardial infarction is an uncommon disease in young 
adults and its incidence varies between 2% and 10%, ac-
cording to different surveys (1-4). In most of published 
studies, the definition of young patients included individu-
Abstract
Objectives. Myocardial infarction is a relatively unusual phenom-
enon in young subjects. The aim if this work is to characterize the 
risk profile and  factors influencing outcomes of these patients since 
it  makes  possible to manage prevention interventions. 
Patients and Methods. We examined cardiovascular risk factors, 
clinical presentation, angiographic picture and outcome of a group of 
young patients hospitalized for a myocardial infarction. We enrolled 
121 young patients consecutively admitted to our hospital for a myo-
cardial infarction and examined them not only at the initial stage, but 
also after 3 months and one year; finally a long-term telephonic follow 
up was performed, when possible. 
Results. We found some peculiarity making these patients quite 
different from the older ones who develop a myocardial infarction: 
cigarettes smoking, family history of ischemic heart disease and hy-
perlipidemia were the most frequent cardiovascular risk factors, while 
diabetes and hypertension were less represented; moreover coronary 
angiography showed more frequently a less extensive coronary athero-
sclerosis. Patients who developed a cardiovascular event at follow-up 
presented a significantly higher prevalence of hypertension and obesity 
and a significantly lower frequency of healthy coronary arteries and of 
previous revascularization. 
Conclusions. Myocardial infarction in young adults presents sev-
eral peculiarities, represented not only by the risk profile, but also by 
the angiographic picture and the prognosis. Considering the long life 
expectancy of the involved population, the essential role of preventive 
interventions should be strongly underlined. Clin Ter 2013; 164(2):e77-
82.   doi: 10.7417/CT.2013.1535            
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als aged less than 45. Although these patients account for 
only a minor proportion of all patients with acute coronary 
syndromes, this population is of particular interest because 
of the long life expectancy. 
In the past, it has been demonstrated that young subjects 
who develop a myocardial infarction present peculiar genetic 
(5-7) and laboratory characteristics (8-14). 
In this paper we focused our attention on risk factors, 
clinical presentation, angiographic characteristics and out-
come of a group of young patients admitted to the emergency 
department for an acute myocardial infarction. 
Materials and Methods
We performed a prospective study enrolling young 
adults (aged less than 45 years) with ST elevation acute 
myocardial infarction (STEMI) or non-ST elevation acute 
myocardial infarction (NSTEMI). Patients were admitted 
either from the emergency department of our hospital or 
were transferred from other hospitals of Western Sicily. 
We enrolled all consecutive patients who were diagnosed 
with an acute myocardial infarction (AMI), according to 
the World Health Organization criteria (15). Demographic 
characteristics included age and sex. The risk profile of each 
patient was investigated. Family history of coronary heart 
disease was defined as any first-degree relative younger 
than 55 years who was affected by ischemic heart disease. 
Each person who smoked at least one cigarette/day was 
defined smoker. Overweight was defined by an increased 
BMI ranging from 25 to 29.9 kg/m2 and obesity by ì BMI 
≥30 Kg/m2. Hypertension was defined as a systolic blood 
pressure > 140 mmHg and/or a diastolic blood pressure >90 
mmHg and/or the use of anti-hypertensive drugs. Hyperlipi-
demia was defined as a total plasma cholesterol >220 mg/
dl and/or the use of cholesterol-lowering agents. Diabetes 
was defined as a fasting glycaemia >126 mg/dl and/or the 
use of oral or insulin therapy. It was also investigated the 
personal history of ischemic heart disease. In females, the 
use of oral contraceptives was evaluated. Finally, the use of 
cocaine was considered. 
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Concerning clinical presentation, patients were divided 
in two groups according to the type of myocardial infarction: 
STEMI and NSTEMI patients.
Angiographic characteristics were investigated and pa-
tients were divided in three different groups according to the 
angiographic picture: patients without significant coronary 
stenosis, patients with a single vessel disease (in which a 
>70% stenosis was present in one coronary artery) and pa-
tients with a multi vessel disease (in which a > 70% stenosis 
was present in at least two coronary arteries). Furthermore, 
in patients with significant coronary disease the occurrence 
of revascularization (PCI or CABG) was analyzed. 
Ejection fraction was analyzed too. Finally, the discharge 
therapy was investigated. 
Enrolled patients were examined three months and one 
year after the discharge, performing an ECG and a visit and it 
was evaluated the recurrence of ischemic events and the occur-
rence of heart failure. A long term telephonic follow-up was 
also performed. New episodes of angina or infarction were 
investigated as well as the presence of heart failure. Informed 
consent was obtained from participants in the study. 
Concerning statistical analysis, continuous variables 
were expressed as mean ± SD and categorical variables 
as proportions. Summary measurements were compared 
between groups using t Student test, for unpaired data, and 
chi-square test or Fisher exact test, for frequencies. Statistical 
significance was set at the conventional p ≤0.05 level.
Results 
Demographic characteristics and cardiovascular risk fac-
tors are listed in Table 1. Since June 2001, 121 AMI patients 
were enrolled. The mean age was 39.7 ± 5.3. Among these 
patients, 110 (91%, mean age 39.6) were males and 11 patients 
(9%, mean age 40.6) were females. The most frequent risk 
factors were cigarettes smoking (74.4%), family history of 
ischemic heart disease (56.1%) and hyperlipidemia (47.1%). 
Among the 88 patients who smoked, the 75% used to smoke 
more than 20 cigarettes/day, 23% smoked 10-20 cigarettes/
day and only 2% smoked less than 10 cigarettes/day. Dividing 
our population according to BMI, 25.1% were obese, 44.6% 
were in overweight and only 29.7% had a normal BMI. Hy-
pertension and diabetes were less frequent risk factors (20.7% 
and 9.9%, respectively). A personal history of ischemic heart 
disease was present in 9% of our sample. Three patients ad-
mitted the use of cocaine. Among the 11 enrolled women, 5 
(45.5%) took oral contraceptives. At the same time, these 5 
women were smokers. Only 7 patients (3.3%) didn’t present 
any of the studied cardiovascular risk factors. 
Concerning clinical presentation, 86 patients (71%) 
were admitted with a STEMI, while 34 patients (28%) 
had a NSTEMI. In one case, it was not possible to obtain 
information about the clinical picture at the hospitaliza-
tion. Localization of infarction was anterior in 60 subjects 
(49.6%), inferior in 60 subjects (49.6%) and indefinite in 
1 subject (0.8%). 
Angiographic picture was assessed in 114 patients; in 
7 individuals coronary angiography was not performed for 
various reasons (it was refused by the patient or not recom-
mended by the physician). Young patients were more likely 
to have a single-vessel disease (43% of the sample, n=49). A 
multi vessel disease was found in the 27% of patients (n=31), 
while the 25% (n=29) presented normal coronaries. In these 
latter patients an alternative diagnosis, such as myocarditis 
or pericarditis, was ruled out on the basis of the clinical, 
electrocardiographic and echocardiographic picture and of 
the laboratory data; STEMI was diagnosed in the 65.5% of 
these cases (n=19; 12 of them underwent fibrinolysis) while 
NSTEMI in the 34.5% (n=10). 
Finally five patients showed a non-atherosclerotic origin 
of the myocardial infarction (coronary ectasia, coronary 
spasm, myocardial bridging). 
Among the 114 patients who underwent coronary an-
giography, 80 presented a significant coronary stenosis. 
Among these 68 (85%) were subjected to a revascularization 
procedure: 60 underwent PCI and 8 CABG. 
Echocardiographic data were available for 113 patients. 
The mean ejection fraction was 54.6% ± 7.8 (range 35-75%). 
A moderate left ventricular dysfunction (i.e., EF ≤45%) was 
present in 17 subjects (15%). 
At discharge 55 patients (45.4%) took aspirin, 12 (9.9%) 
took aspirin and ticlopidin, 42 (34.7%) took aspirin and 
clopidogrel, 9 (7.4%) ticlopidin and 3 (2.5%) took anticoagu-
lants. Beta-blokers were recommended to 80 patients (66%), 
statins to 92 (76%) and ACE-inhibitors to 64 (52.9%). 
Three months follow up was obtained from 111 patients. 
In this period the 9% of patients (n=10) were admitted to 
the emergency department for an ischemic event and the 8% 
(n=9) developed heart failure. Statistical analysis showed 
that the only risk factor significantly associated with a new 
event at short term follow up was hypertension; a trend 
towards statistical significance is also present in the distribu-
tion of diabetes (Table 2). 
Moreover, the absence of coronary stenosis and previous 
revascularization interventions (performed in the acute or 
subacute phase of myocardial infarction) were significantly 
associated with the absence of events while the localization 
of the culprit lesion in left anterior descending artery was 
significantly associated with the recurrence of ischemic 
events (Table 3). 
Table 1. Demographic characteristics and cardiovascular risk factors 
(n=121).
Age (mean ± SD) 39.7 ± 5.3
Male n (%) 110 (91%)
Smoke habit n (%) 90 (74.4%)
Family history of ischemic heart disease n (%) 68 (56.1%)
Hyperlipidemia n (%) 57 (47.1%)
BMI >30 Kg/m2 n (%) 31 (25.1%)
BMI  25-29.9 Kg/m2 n (%) 54 (44.6%)
BMI <25 Kg/m2 n (%) 36 (29.7%)
Diabetes mellitus n (%) 25 (20.7%)
Hypertension n (%) 12 (9.9%)
Women taking oral contraceptives n (%) 5 (45.5%)
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Table 2. New ischemic events at three months follow-up and cardiovascular risk factors (n=111).
New event
All Yes n=10 No n=101 p
Age  (mean ± SD) 39.8 ± 5.4 42.1 ± 2,6 39.6 ± 5.6 0.2
Male n (%) 101( 91%) 8 (80%) 93 (92%) 0.2
Smoke habit n (%) 83 (74.8%) 7 (70%) 76 (75%) 0.4
Family history of ischemic heart disease n (%) 62 (55.9%) 7 (70%) 55 (54%) 0.2
Hyperlipidemia n (%) 53 (47.7%) 5 (50%) 48 (47%) 0.5
BMI > 30 Kg/m2 n (%) 26 (25.0%) 4 (40%) 22 (23%) 0.2
BMI  (mean ± SD) 29.8 ± 4.35 32.7 ± 7.5 28.7 ± 3.8 0.1
Diabetes mellitus n (%) 12 (10.9%) 3 (30%) 9 (9%) 0.07
Hypertension n (%) 26 (23.4%) 5 (50%) 21 (21%) 0.05*
Absence of cardiovascular risk factors n (%) 6 (5.4%) 0 6 (6%) 0.5
*Fisher exact test
Table 3. New ischemic events at three months follow-up and angiographic and echocardiographic picture (n=111).
New event
All Yes n=10 No n=101 p
STEMI n (%) 80 (72.7%) 6 (60%) 74 (74%) 0.2
Anterior  infarction n (%) 56 (50.5%) 7 (70%) 49 (48%) 0.16
Healthy  coronaries n (%) 28 (27.7%) 0 (0%) 28 (30%) 0.04*
Involvement of ADA n (%) 46 (52.9%) 8 (89%) 38 (49%) 0.02*
EF  <45% n (%) 15 (14.6%) 2 (22%) 13 (14%) 0,38
Previous revascularization 63 (78.8%) 5 (50%) 58 (83%) 0.03*
*Fisher exact test
Data about one year follow-up are available from 95 
patients: 13.5% (n=13) of them were hospitalized for a new 
ischemic event and the 2.1% (n=2) developed new heart 
failure. In this subgroup age, hypertension and obesity were 
associated with a new episode of angina or infarction and a 
trend towards significance is present in the distribution of 
diabetes (Table 4). 
Data about one year follow-up confirm the trend of the 
short term follow-up being the absence of coronary stenosis 
and previous revascularization interventions significantly 
associated with the absence of new events (Table 5). 
Finally, long term follow-up (4.9±1.6 years) was com-
pleted in 69 patients: 20.2% (n=14) developed a new isch-
emic event and 4.3% (n=3) developed new heart failure. No 
cardiovascular risk factor was significantly associated with 
new events. A trend towards statistical significance could be 
noted in the frequency of diabetes, hypertension and obesity, 
being these risk factors more frequent in the subgroup of 
patients who develop a new ischemic episode (Table 6). 
The only characteristic significantly associated with a 
better prognosis was the presence of healthy coronaries while 
the presence of an EF <45% was significantly associated 
with the recurrence of events (Table 7).
 
Discussion
The study of ischemic heart disease in young individuals 
is important in the era of preventive cardiology. Data from 
literature indicate that nearly the 10% of all patients hospi-
talized for AMI are <45 year old (3, 16-21). Thus, taking 
into account that the early onset of ischemic heart disease is 
not so rare, the evaluation of its risk profile, clinical features 
and prognosis may have a relevant clinical impact for risk 
factors modification and for the improvement of primary 
and secondary prevention. 
Previous studies suggested that myocardial infarction 
is predominantly a disease of male (21, 22). Overall, 91% 
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Table 5. New ischemic events at one year follow-up and angiographic and echocardiographic picture (n=95).
New event
All Yes n=13 No n=82 p
STEMI n (%) 68 (72.3%) 8 (61%) 60 (74%) 0.2
Anterior infarction n (%) 48 (50.5%) 7 (54%) 41 (50%) 0.5
Healthy coronaries n (%) 26 (29.9%) 1 (8%) 25 (34%) 0.05*
Involvement of ADA n (%) 40 (54.1%) 7 (58%) 33 (53%) 0.4 
EF  <45% n (%) 11 (12.5%) 3 (27%) 8 (10%) 0.13
Previous revascularization 54 (81.8%) 5 (45%) 49 (89%) 0.002*
* Fisher exact test
Table 4. New ischemic events at one year follow-up  and cardiovascular risk factors (n=95).
New event
All Yes n=13 No n=82 p
Age (mean ± SD) 39.9 ± 5.6 43 ± 1.9 39.4 ± 5.8 0.01# 
Male n (%) 86 (90.5%) 12 (92%) 74 (90%) 0.6
Smoke habit  n (%) 71 (74.7%) 10 (76%) 61 (74%) 0.4
Family history of ischemic heart disease n (%) 52 (54.7%) 10 (77%) 42 (51%) 0.07
Hyperlipidemia n (%) 48 (50.5%) 8 (61%) 40 (49%) 0.2
BMI > 30 Kg/m2 n (%) 23 (25.6%) 5 (42%) 18 (23%) 0.1
BMI (mean ± SD) 28.9 ± 4.3 32.4 ± 6.6 28.4 ± 3.5 005#
Diabetes mellitus n (%) 10 (10.6%) 3 (23%) 7 (9%) 0.1 
Hypertension n (%) 21 (22.1%) 6 (46%) 15 (18%) 0.03*
Absence of cardiovascular risk factors n (%) 5 (5.3%) 1 (8%) 4 (5%) 0.5
Table 6. New ischemic events at long-time follow-up and cardiovascular risk factors (n=69).
New event
All Yes n=14 No n=55 p
Age (mean ± SD) 41.0 ± 3.8 42.1 ± 2.6 40.8 ± 4.1 0.2
Male n (%) 63 (91.3%) 13 (93%) 50 (91%) 0.6
Smoke habit n (%) 50 (72.5%) 10 (71%) 40 (73%) 0.5
Family history of ischemic heart disease n (%) 40 (58.0%) 8 (57%) 32 (58%) 0.5
Hyperlipidemia n (%) 37 (53.6%) 8 (57%) 29 (53%) 0.5
BMI > 30 Kg/m2 n (%) 17 (25.8%) 5 (38%) 12 (23%) 0.2
BMI  (mean ± SD) 28.9 ± 4.3 30.6 ± 3.4 28.6 ± 3.8 0.1
Diabetes mellitus n (%) 8 (11.6%) 3 (21%) 5 (9%) 0.1
Hypertension n (%) 19 (27.5%) 6 (43%) 13 (24%) 0.1
Absence of cardiovascular risk factors n (%) 4 (5.8%) 1 (7%) 3 (5%) 0.6
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of our patients were male, confirming literature data. Epi-
demiologic differences related to sex become less evident 
when older individuals are examined (21). 
A peculiarity of populations composed of young pa-
tients with AMI is represented by the risk profile. Cigarette 
smoking is uniformly the most common risk factor in many 
surveys, with an incidence ranging from 70% to more than 
90% (1, 2, 21, 23-25). The current study confirms that a 
preponderance of young patients with AMI reported using 
tobacco at the time of the event. Many mechanisms are 
hypothesized to explain the role of smoking in the develop-
ment of coronary heart disease: it plays, in fact, a role, not 
only in atherogenesis, but also in thrombogenesis, as well 
as in the development of endothelial dysfunction, favoring 
coronary spasm. These characteristics may help to explain 
the frequent found of healthy coronaries or of a non critical 
coronary atherosclerosis. 
A family history of coronary heart disease is considered 
one of the most relevant risk factors for the early onset of 
AMI (1, 2, 21). Mechanisms regulating the heredity of the 
predisposition to develop atherosclerosis and its complica-
tions are not fully explained, but recently it has been widely 
demonstrated that genetic background may play a role in the 
risk of ischemic heart disease (26-28). 
Finally, hypertension and diabetes mellitus, well estab-
lished cardiovascular risk factors, are not as prevalent in 
younger age groups as they are in older ones. This observation 
is consistent with several studies (2, 3, 16, 21, 23, 29). 
The low incidence of AMI in women limited the pos-
sibility to investigate adequately their risk profile. In this 
small sub-population oral contraceptives are an additive risk 
factor: approximately 40% of the female patients were tak-
ing oral contraceptives. Moreover all of them were smokers, 
confirming the synergic prothrombotic action of cigarettes 
and contraceptives. 
Regarding the extent of coronary atherosclerosis, young 
patients generally show a less evolved disease. Coronary 
angiography demonstrated, in fact, an absence of significant 
coronary stenosis in the 25% of our patients and the pres-
ence of a single-vessel disease in the 43% of them. In these 
cases, myocardial infarction might be interpreted as the 
consequence of an acute thrombotic event, even on healthy 
or not critically stenosed coronaries. These data confirm 
previous literature observations (2, 16, 21, 30). Moreover 
in young patients it is less rare to find a non atherosclerotic 
mechanism of the ischemia: coronary ectasia, coronary 
spasm, coronary inflammation or coronary bridging. 
Discharge therapy in our population of young AMI pa-
tients was in agreement with currently recommended treat-
ment: 97.5% was taking an anti-platelet agent, 76% statin 
and 66% beta-blocker. Nearly the 45% of our patients were 
discharged with double-antiaggregation. This fact might be 
explained taking into account that the enrollment started 
on 2001 and the use of a second antiplatelet agent in acute 
myocardial infarction was not common at that time. 
Follow up data show an increase in rates of new isch-
emic events during the studied period. Unfortunately just 
approximately half of our patients were available for a long 
term follow-up and this is a limitation of this study. In fact 
we are not able to estimate the real mortality of this group 
of patients. The reason of this lack of patients should be 
found in the distance between our center and the site of 
provenience of some of them. 
Short and medium time follow up events showed that 
patients who developed a new cardiovascular event were 
more likely hypertensive and obese, with a trend towards the 
statistic significance for diabetes. At long term follow-up no 
cardiovascular risk factor resulted significantly associated 
with a recurrent event. This datum could be explained as 
a consequence of the small sample size. Interestingly, risk 
factors more often associated with coronary artery disease 
in older patients (i.e. hypertension and diabetes) were less 
frequent in this young population, but they showed a relevant 
prognostic role. 
Prognosis seemed to be also affected by angiographic 
picture and by the occurrence of revascularization. In fact, 
both at the early and at the medium time follow up, the ab-
sence of significant coronary stenosis was associated with a 
better prognosis as it was also a previous revascularization 
(PCI or CABG). 
The presence of healthy coronary arteries has a posi-
tive prognostic impact also at long time follow-up, while a 
decreased ejection fraction is associated with the recurrence 
of events. These data confirm the poor published data about 
prognosis of young patients with myocardial infarction (31, 
32). 
Table 7. New ischemic events at long-time follow-up and angiographic and echocardiographic picture (n=69).
New event 
All Yes n=14 No n=55 p
STEMI n (%) 49 (71.0%) 10 (71%) 39 (71%) 0.6
Anterior infarction n (%) 33 (47.8%) 9 (64%) 24 (43%) 0.1
Healthy coronaries n (%) 20 (31.3%) 1 (8%) 19 (37%) 0.03*
Involvement of ADA n (%) 26 (50.0%) 8 (61%) 18 (46%) 0.2 
EF  <45% n (%) 8 (12.5%) 4 (33%) 4 (8%) 0.03*
Previous revascularization 40 (83.3%) 9 (69%) 31 (89%) 0.12
*Fisher exact test
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In conclusion, despite partial information about the 
long-term follow-up of this group of young subjects with 
AMI, we retain of particular interest the description of risk 
factors and of clinical and angiographic picture that seem 
to affect prognosis. 
Risk profile in these subjects is quite different from 
the one of older populations, as it is angiographic picture. 
Nevertheless a deep impact on prognosis seems to be 
played by those risk factors which are more frequent in 
older patients. 
Considering the long life expectancy of these patients 
and their peculiarities, we believe that the study of their 
characteristics deserves a deep attention that needs further 
investigation especially enlarging the record of cases. 
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